MyLab E80 Esaote ultrasound system (Photo: Esaote)
Nov. 13, 2025 — Esaote has announced a new strategic partnership with Schiller Americas. This collaboration strengthens both companies' presence in the cardiovascular imaging market and marks a major step forward in bringing Esaote's advanced ultrasound technology to more U.S. healthcare providers.
Through this partnership, Schiller Americas will offer Esaote's ultrasound systems — including the MyLab E80, MyLab A70, and MyLab Omega eXP — to its extensive cardiology network across the United States. The synergy between the two companies creates a powerful portfolio that delivers comprehensive diagnostic solutions designed to improve cardiac care and patient outcomes.
"Esaote and Schiller have shared a strong global relationship for many years, and we're thrilled to expand that collaboration into the U.S. market" said Thomas Will, Director of Ultrasound Sales at Esaote North America. "Our product lines complement each other perfectly, combining Schiller's excellence in cardiopulmonary diagnostics with Esaote's leadership in ultrasound imaging, to provide clinicians with a more complete diagnostic toolkit".
"This partnership represents a significant step forward in improving diagnostic accuracy in the U.S.cardiopulmonary field" said Francesco Iacona, CEO of Schiller Americas. "By combining Esaote's ultrasound imaging expertise with our leadership in cardiopulmonary diagnostics, we are establishing a new standard for comprehensive diagnostic solutions for clinicians".
The partnership underscores both organizations' shared commitment to advancing cardiovascular imaging, providing physicians with high-quality, flexible solutions that enhance diagnostic precision and workflow efficiency.
For more information, please visit www.esaote.com or schillerus.com.
January 16, 2026 
